• News /
  • < 1 minute read

Enter at Your Own Risk: FDA Draft Guidance Highlights the Uncertainty in the Abbreviated Biosimilar Approval Pathway

Private: James V. DeGiulio
  • Spring 2012 (snippets)
Private: James V. DeGiulio

Practices & Technologies

Counseling Litigation & Appeals Patent Prosecution Biotechnology & Pharmaceuticals Chemical Software & Business Methods Electrical Mechanical & Materials Medical Device & Diagnostics Telecommunications
People
ABCDEFGHIJKLMNOPQRSTUVWXYZ
Services
Practices Technologies
Intelligence
NewsEventsSnippetsPatently-O BlogPatent Docs
Firm
Coronavirus UpdateDiversity & InclusionCommunityAwards & AccoladesOur Clients
Careers
Life at MBHB Growth Opportunities Business Professionals Legal Professionals
LocationsContact Us